And for the survival analyses of OS, high expressions of SLC19A1, CYC1, RRM2B, and OCRL and downregulation of RPS14 were significantly related to more unfavorable OS in breast cancer, which further confirmed the validity of selected genes. The gene discussed is RRM2B; the disease is breast cancer.